Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
KUAISHOU-W
01024
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 379.84%347K | ---- | 92.97%-124K | ---- | 83.64%-1.76M | ---- | -226.85%-10.77M | ---- | -914.15%-3.3M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -33.33%-16K | ---- | -71.43%-12K | ---- | 30.00%-7K | ---- | 60.00%-10K | ---- | -19.05%-25K |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | -99.06%1K | ---- | --106K | ---- | ---- |
| Impairment and provisions: | ---- | 305.47%263K | ---- | -131.84%-128K | ---- | -95.29%402K | ---- | 15,688.89%8.53M | ---- | --54K |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --334K | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | --378K | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 305.47%263K | ---- | -633.33%-128K | ---- | -99.71%24K | ---- | 15,070.37%8.19M | ---- | --54K |
| Asset sale loss (gain): | ---- | 51.72%-210K | ---- | ---435K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---435K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---210K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 56.05%245K | ---- | 103.90%157K | ---- | -63.51%77K | ---- | -25.70%211K | ---- | -17.44%284K |
| Financial expense | ---- | -33.80%47K | ---- | 51.06%71K | ---- | 23.68%47K | ---- | -7.32%38K | ---- | -28.07%41K |
| Operating profit before the change of operating capital | ---- | 243.52%676K | ---- | 62.11%-471K | ---- | 34.65%-1.24M | ---- | 35.35%-1.9M | ---- | -5,449.09%-2.94M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -524.39%-696K | ---- | 182.41%164K | ---- | -150.13%-199K | ---- | 18.15%397K | ---- | 20.43%336K |
| Accounts payable increase (decrease) | ---- | 178.65%151K | ---- | -0.52%-192K | ---- | -16.46%-191K | ---- | -21.48%-164K | ---- | -126.42%-135K |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | -92.63%79K | ---- | 38.86%1.07M | ---- | 156.68%772K |
| Cash from business operations | ---- | 126.25%131K | ---- | 67.89%-499K | ---- | -160.30%-1.55M | ---- | 69.68%-597K | ---- | -280.85%-1.97M |
| Other taxs | ---- | ---- | ---- | ---- | ---- | 98.45%-2K | ---- | 57.14%-129K | ---- | 19.30%-301K |
| Special items of business | 86.65%-127K | -135.10%-844K | 16.58%-951K | ---359K | -1.79%-1.14M | ---- | -241.46%-1.12M | ---- | 85.55%-328K | ---- |
| Net cash from operations | 86.65%-127K | 16.90%-713K | 16.58%-951K | 44.86%-858K | -1.79%-1.14M | -114.33%-1.56M | -241.46%-1.12M | 68.02%-726K | 85.55%-328K | -155.06%-2.27M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -50.00%1K | 33.33%16K | -33.33%2K | 71.43%12K | 0.00%3K | -30.00%7K | -50.00%3K | -60.00%10K | -76.00%6K | 19.05%25K |
| Sale of fixed assets | ---- | ---- | ---- | --780K | --780K | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | -28.57%-36K | -587.50%-110K | -2,700.00%-28K | 57.89%-16K | 95.24%-1K | 17.39%-38K | 16.00%-21K | 30.30%-46K | 62.12%-25K | 31.25%-66K |
| Recovery of cash from investments | ---- | --1.49M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -34.62%-35K | 79.25%1.39M | -103.32%-26K | 2,603.23%776K | 4,444.44%782K | 13.89%-31K | 5.26%-18K | 12.20%-36K | 53.66%-19K | 45.33%-41K |
| Net cash before financing | 83.42%-162K | 926.83%678K | -172.91%-977K | 94.83%-82K | 68.54%-358K | -108.27%-1.59M | -227.95%-1.14M | 67.03%-762K | 84.98%-347K | -139.48%-2.31M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -48.52%157K | ---- | --305K | ---- | ---- | ---- | --4K | --3K | ---- | ---- |
| Refund | ---- | -2,153.33%-1.01M | -9.52%-23K | -155.56%-45K | 12.50%-21K | 265.31%81K | 0.00%-24K | 44.32%-49K | 72.73%-24K | 81.70%-88K |
| Interest paid - financing | 82.35%-6K | 33.80%-47K | 2.86%-34K | -51.06%-71K | -84.21%-35K | -23.68%-47K | -18.75%-19K | 7.32%-38K | 60.98%-16K | 28.07%-41K |
| Net cash from financing operations | -87.05%18K | -312.06%-1.3M | 201.46%139K | -208.82%-315K | -45.74%-137K | 46.60%-102K | 13.76%-94K | 32.51%-191K | 61.48%-109K | -103.93%-283K |
| Effect of rate | -900.00%-40K | 3.23%-30K | -144.44%-4K | -24.00%-31K | 400.00%9K | -186.21%-25K | -107.69%-3K | 222.22%29K | 333.33%39K | 115.79%9K |
| Net Cash | 82.82%-144K | -56.17%-620K | -69.29%-838K | 76.49%-397K | 59.82%-495K | -77.23%-1.69M | -170.18%-1.23M | 63.26%-953K | 82.42%-456K | -141.62%-2.59M |
| Begining period cash | -37.40%1.09M | -19.76%1.74M | -19.76%1.74M | -44.18%2.17M | -44.18%2.17M | -19.23%3.88M | -19.23%3.88M | -34.98%4.8M | -34.98%4.8M | 508.65%7.39M |
| Cash at the end | 0.89%904K | -37.40%1.09M | -46.67%896K | -19.76%1.74M | -36.48%1.68M | -44.18%2.17M | -39.71%2.65M | -19.23%3.88M | -8.68%4.39M | -34.98%4.8M |
| Cash balance analysis | ||||||||||
| Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | National Health Accounting Firm Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.